Saki Shimizu

Saki Shimizu is an experienced individual with a background in pharmaceutical science and molecular virology. They have worked in various companies and research institutions, focusing on the development of gene therapies and cell-based therapies for neurological disorders, cancer, and infectious diseases. Their expertise lies in AAV gene therapy development, lentivirus vector design, T cell therapy, and stem cell therapy. Shimizu has also been involved in projects related to humanized mouse models and FACS analysis. Additionally, they have experience as a teaching assistant and have completed degrees in pharmaceutical science, medical science, and molecular virology.